Lupin receives EIR from USFDA for Nagpur injectable facility
The EIR was issued following an inspection of the facility from September 8 to September 16, 2025
The EIR was issued following an inspection of the facility from September 8 to September 16, 2025
India plays a critical role in Bristol Myers Squibb’s global strategy
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
In her previous roles, Menon led significant digital transformation efforts, implementing predictive analytics, automation
The innovation -- UPM Circular Renewable Black -- is the world’s first bio-based, near-infrared (NIR) detectable, carbon-negative black
The Healey ALS Platform Trial is a multicenter, double-blind, placebo-controlled
This strategic investment aims to bolster the company's position as a global leader in Vitamin D3 manufacturing
The collaboration will establish the MUMPMP–Agilent BioDiscovery Hub
Subscribe To Our Newsletter & Stay Updated